Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR
NCT03410654Phase 1Completed
- Sponsor
- Yale University
- Start
- Oct 2018
- Primary completion
- Jan 2024
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tacrolimus in kidney transplantation, sponsored by Yale University. Primary endpoints: Cognitive Assessment at Baseline and Cognitive Improvement from Baseline at 3 months. Started Oct 2018; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT03410654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410654.